September 8, 2024

whiskeygingershop

Learn new things

CASI Pharmaceuticals Announces Appointment Of Chief Economic Officer

ROCKVILLE, Md., and BEIJING, Dec. 16, 2020 /PRNewswire/ — CASI Prescribed drugs, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical firm targeted on creating and commercializing revolutionary therapeutics and pharmaceutical products, currently announces the appointment of Weihao Xu to the placement of Chief Financial Officer. Mr. Xu will report to Dr. Wei-Wu He, Chairman and CEO of CASI.

Most just lately, in January 2020, Mr. Xu started and served as Chief Expense Officer for Permanence Money LLC, a health care-dedicated expense organization. From February 2018 until March 2019, he served as Chief Financial Officer for 111, Inc. a Shanghai-dependent electronic healthcare organization, in which he led the initial community supplying of the enterprise on NASDAQ, and oversaw the company’s money functions, corporate method and investor relations. Prior to that, Mr. Xu served as a portfolio manager and expenditure analyst at Matthews Global Money Administration LLC, a San Francisco-centered investment agency focusing on investing in Asia, from 2016 to 2018 and subsequently from 2019 to 2020. He also served as head of emerging markets and portfolio manager in New York at Permal Asset Management LLC from 2014 to 2016 and investment analyst in London at Lansdowne Associates from 2012 to 2014. Mr. Xu retains a Grasp of Philosophy degree in Accounting from Columbia Business Faculty.

“We are incredibly pleased to welcome Weihao to our management group. His exceptional experience encompasses both that of a health care-centered get-side experienced and of a CFO  overseeing economic operations, which include places of economic planning and fundraising. These techniques will empower him to substantially add to driving a quantity of our planned strategic initiatives forward in 2021 and outside of,” claimed Dr. He.

About CASI Prescription drugs

CASI Prescription drugs, Inc. (“CASI” or the “Company”) is a U.S. biopharmaceutical enterprise focused on building and commercializing impressive therapeutics and pharmaceutical products in China, the United States, and throughout the planet. The Enterprise is targeted on obtaining, producing and commercializing items that augment its hematology oncology therapeutic concentrate as effectively as other spots of unmet health-related require. The Enterprise intends to execute its system to turn out to be a chief by launching medicines in the better China sector leveraging the Company’s China-based regulatory and business competencies and its worldwide drug enhancement expertise. The Company’s functions in China are executed by its wholly-owned subsidiary, CASI Prescribed drugs (China) Co., Ltd., which is positioned in Beijing, China. The Business has crafted a business team of above 70 hematology and oncology gross sales and internet marketing professionals primarily based in China. Much more details on CASI is offered at www.casipharmaceuticals.com.

Ahead-On the lookout Statements

This news release has forward-hunting statements inside of the indicating of the Non-public Securities Litigation Reform Act with regard to the outlook for anticipations for upcoming economical or enterprise general performance, income expansion, approaches, anticipations and targets. Forward-searching statements are topic to several assumptions, hazards and uncertainties, which adjust around time. Ahead-looking statements discuss only as of the day they are produced, and we presume no obligation to update forward-seeking statements. New things arise from time to time, and it is not feasible for us to forecast which components will crop up. In addition, we can not assess the effects of each individual component on our enterprise or the extent to which any issue, or combination of variables, may well induce real success to vary materially from those people contained in any forward-wanting statements. Precise benefits could differ materially from these at present expected thanks to a selection of factors.

Resource CASI Prescribed drugs, Inc.

Similar Back links

https://www.casipharmaceuticals.com/